The benefits of Taxol in cancer treatment are well-documented. It has been shown to improve survival rates and reduce the risk of cancer recurrence in many patients. Its ability to be combined with other chemotherapy agents enhances its efficacy, making it a cornerstone in combination therapy protocols.